EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Clinical review 83: Mechanisms of glucocorticoid action in bone: implications to glucocorticoid-induced osteoporosis



Clinical review 83: Mechanisms of glucocorticoid action in bone: implications to glucocorticoid-induced osteoporosis



Journal of Clinical Endocrinology and Metabolism 81(10): 3441-3447



The term extranodal lymphoma refers to lymphoma arising in tissues other than lymph nodes or major lymphoid organs (1). The GI tract is commonly involved by lymphoma. Although lymphomas of the liver and the biliary tree are uncommon, they are well described in the literature. However, there are only nine cases of primary lymphoma of the gallbladder reported in the English literature.

(PDF emailed within 0-6 h: $19.90)

Accession: 008323057

Download citation: RISBibTeXText

PMID: 8855781

DOI: 10.1210/jcem.81.10.8855781



Related references

Glucocorticoid and Bone. Beneficial effect of teriparatide on fracture risk as well as bone mineral density in patients with glucocorticoid-induced osteoporosis. Clinical Calcium 24(9): 1379-1385, 2015

Glucocorticoid and Bone. Efficacy and safety of bisphosphonate in treatment of glucocorticoid induced osteoporosis. Clinical Calcium 24(9): 1371-1378, 2015

Glucocorticoid and Bone. The changes of Japanese and foreign guidelines for the management of glucocorticoid-induced osteoporosis. Clinical Calcium 24(9): 1301-1308, 2015

Glucocorticoid and Bone. Updated Japanese guidelines for the management of glucocorticoid-induced osteoporosis. Clinical Calcium 24(9): 1309-1318, 2015

Glucocorticoid and Bone. Collagen cross-link abnormalities in glucocorticoid induced osteoporosis. Clinical Calcium 24(9): 1351-1359, 2015

Glucocorticoid and Bone. Efficacy of active vitamin D on glucocorticoid-induced osteoporosis. Clinical Calcium 24(9): 1387-1392, 2015

Tetramethylpyrazine Protects Against Glucocorticoid-Induced Apoptosis by Promoting Autophagy in Mesenchymal Stem Cells and Improves Bone Mass in Glucocorticoid-Induced Osteoporosis Rats. Stem Cells and Development 26(6): 419-430, 2016

Glucocorticoid and Bone. Pathogenesis of glucocorticoid-induced osteoporosis. Clinical Calcium 24(9): 1289-1294, 2015

Baseline glucocorticoid dose and bone mineral density response with teriparatide or alendronate therapy in patients with glucocorticoid-induced osteoporosis. Journal of Rheumatology 37(1): 141-148, 2010

Mechanisms of bone loss in glucocorticoid-induced osteoporosis. Journal of Endocrinology 160(SUPPL ): S32, March, 1999

Glucocorticoid-induced osteoporosis: skeletal manifestations of glucocorticoid use and 2004 Japanese Society for Bone and Mineral Research-proposed guidelines for its management. Modern Rheumatology 15(3): 163-168, 2006

Glucocorticoid-induced osteoporosis: skeletal manifestations of glucocorticoid use and 2004 Japanese Society for Bone and Mineral Research-proposed guidelines for its management. Modern Rheumatology 15(3): 163-168, 2005

Glucocorticoid action and novel mechanisms of steroid resistance: role of glucocorticoid receptor-interacting proteins for glucocorticoid responsiveness. Journal of Endocrinology 178(3): 331-337, 2003

Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis. Arthritis and Rheumatism 44(7): 1496-1503, 2001

Glucocorticoid-induced osteoporosis: mechanisms for bone loss; evaluation of strategies for prevention. Journal of Gerontology 45(5): M153-M158, 1990